Q3 2015 13F Holders as of 9/30/2015
-
Type / Class
-
Equity / Class B Common Stock
-
Shares outstanding
-
5.07M
-
Number of holders
-
239
-
Total 13F shares, excl. options
-
18.7M
-
Shares change
-
+227K
-
Total reported value, excl. options
-
$2.51B
-
Value change
-
+$20.7M
-
Put/Call ratio
-
0.24
-
Number of buys
-
115
-
Number of sells
-
-100
-
Price
-
$134.31
Significant Holders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) as of Q3 2015
259 filings reported holding BIO - BIO-RAD LABORATORIES, INC. - Class B Common Stock as of Q3 2015.
BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) has 239 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.7M shares
.
Largest 10 shareholders include ATLANTA CAPITAL MANAGEMENT CO L L C (1.74M shares), VANGUARD GROUP INC (1.35M shares), ARIEL INVESTMENTS, LLC (1M shares), ACADIAN ASSET MANAGEMENT LLC (838K shares), BlackRock Fund Advisors (698K shares), LEVIN CAPITAL STRATEGIES, L.P. (629K shares), BlackRock Institutional Trust Company, N.A. (613K shares), UBS GLOBAL ASSET MANAGEMENT AMERICAS INC (577K shares), WELLS FARGO & COMPANY/MN (559K shares), and STATE STREET CORP (517K shares).
This table shows the top 239 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.